Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma.
Baron M, Belin L, Cassoux N, Fardeau C, Blaizeau M, Soussain C, Houillier C, Hoang-Xuan K, Gyan E, Le Lez ML, Lavaud A, Soubeyran P, Bodaghi B, Costopoulos M, Leblond V, Touitou V, Maloum K, Errera MH, Roos-Weil D, Le Garff-Tavernier M, Choquet S.
Baron M, et al. Among authors: soussain c.
Blood. 2020 May 14;135(20):1811-1815. doi: 10.1182/blood.2019003073.
Blood. 2020.
PMID: 32125361
Free article.
No abstract available.